209 related articles for article (PubMed ID: 2047660)
21. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy.
Cheasty T; Skinner JA; Rowe B; Threlfall EJ
Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726
[TBL] [Abstract][Full Text] [Related]
22. Isolation and Antimicrobial Susceptibility Profile of Shigella and Salmonella Species from Children with Acute Diarrhoea in Mekelle Hospital and Semen Health Center, Ethiopia.
Gebreegziabher G; Asrat D; W/Amanuel Y; Hagos T
Ethiop J Health Sci; 2018 Mar; 28(2):197-206. PubMed ID: 29983517
[TBL] [Abstract][Full Text] [Related]
23. [Shigellosis in children of the IX region of Chile: clinical and epidemiologic aspects and antibiotic sensitivity].
Boehme C; RodrÃguez G; Illesca V; Reydet P; Serra J
Rev Med Chil; 1992 Nov; 120(11):1261-6. PubMed ID: 1340946
[TBL] [Abstract][Full Text] [Related]
24. Shigellosis in Thai children: epidemiologic, clinical and laboratory features.
Thisyakorn US; Rienprayoon S
Pediatr Infect Dis J; 1992 Mar; 11(3):213-5. PubMed ID: 1565537
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.
Haltalin KC; Nelson JD; Kusmiesz HT
Arch Dis Child; 1973 Apr; 48(4):305-12. PubMed ID: 4574641
[TBL] [Abstract][Full Text] [Related]
26. Trimethoprim-sulfamethoxazole therapy for shigellosis.
Nelson JD; Kusmiesz H; Jackson LH; Woodman E
JAMA; 1976 Mar; 235(12):1239-43. PubMed ID: 765518
[TBL] [Abstract][Full Text] [Related]
27. Magnitude of drug resistant Shigellosis: a report from Bangalore.
Srinivasa H; Baijayanti M; Raksha Y
Indian J Med Microbiol; 2009; 27(4):358-60. PubMed ID: 19736408
[TBL] [Abstract][Full Text] [Related]
28. Changing patterns of drug-resistant Shigella isolates in egypt.
Abd-Elmeged GM; Khairy RM; Abo-Eloyoon SM; Abdelwahab SF
Microb Drug Resist; 2015 Jun; 21(3):286-91. PubMed ID: 25495749
[TBL] [Abstract][Full Text] [Related]
29. Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.
Gotuzzo E; Oberhelman RA; Maguiña C; Berry SJ; Yi A; Guzman M; Ruiz R; Leon-Barua R; Sack RB
Antimicrob Agents Chemother; 1989 Jul; 33(7):1101-4. PubMed ID: 2675757
[TBL] [Abstract][Full Text] [Related]
30. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014.
Chang Z; Zhang J; Ran L; Sun J; Liu F; Luo L; Zeng L; Wang L; Li Z; Yu H; Liao Q
BMC Infect Dis; 2016 Nov; 16(1):685. PubMed ID: 27863468
[TBL] [Abstract][Full Text] [Related]
31. Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results.
Kaminski N; Bogomolski V; Stalnikowicz R
J Accid Emerg Med; 1994 Sep; 11(3):168-71. PubMed ID: 7804582
[TBL] [Abstract][Full Text] [Related]
32. Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi.
Engels D; Madaras T; Nyandwi S; Murray J
Bull World Health Organ; 1995; 73(6):787-91. PubMed ID: 8907772
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
[TBL] [Abstract][Full Text] [Related]
34. Surveillance of antibiotic susceptibility pattern among shigella flexneri strain isolated in Nagpur district during three years period, January 2009-January 2012.
Dharmik PG; Gomashe AV; Wadher BJ
Indian J Med Sci; 2010 Nov; 64(11):493-500. PubMed ID: 23051941
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and susceptibility of Shigella species to 11 antibiotics in a Kuwait teaching hospital.
Jamal WY; Rotimi VO; Chugh TD; Pal T
J Chemother; 1998 Aug; 10(4):285-90. PubMed ID: 9720466
[TBL] [Abstract][Full Text] [Related]
36. Comparison of trimethoprim-sulfamethoxazole and ampicillin theraphy for shigellosis in ambulatory.
Nelson JD; Kusmiesz H; Jackson LH
J Pediatr; 1976 Sep; 89(3):491-3. PubMed ID: 1048183
[TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibility of Shigella strains isolated from stool cultures of dysenteric patients.
Burstein S; Regalli G
Scand J Gastroenterol Suppl; 1989; 169():34-8. PubMed ID: 2617181
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers.
Tauxe RV; Puhr ND; Wells JG; Hargrett-Bean N; Blake PA
J Infect Dis; 1990 Nov; 162(5):1107-11. PubMed ID: 2230237
[TBL] [Abstract][Full Text] [Related]
39. Randomized clinical trial of norfloxacin for shigellosis.
Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
[TBL] [Abstract][Full Text] [Related]
40. Plasmid-mediated sulfamethoxazole resistance encoded by the sul2 gene in the multidrug-resistant Shigella flexneri 2a isolated from patients with acute diarrhea in Dhaka, Bangladesh.
Iqbal MS; Rahman M; Islam R; Banik A; Amin MB; Akter F; Talukder KA
PLoS One; 2014; 9(1):e85338. PubMed ID: 24416393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
